ID29533A - Senyawa-senyawa kalsilitik - Google Patents

Senyawa-senyawa kalsilitik

Info

Publication number
ID29533A
ID29533A IDW00200101673A ID20011673A ID29533A ID 29533 A ID29533 A ID 29533A ID W00200101673 A IDW00200101673 A ID W00200101673A ID 20011673 A ID20011673 A ID 20011673A ID 29533 A ID29533 A ID 29533A
Authority
ID
Indonesia
Prior art keywords
calsilitic
compounds
calsilitic compounds
Prior art date
Application number
IDW00200101673A
Other languages
English (en)
Inventor
Amparo Maria Lago
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ID29533A publication Critical patent/ID29533A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
IDW00200101673A 1999-02-02 2000-02-02 Senyawa-senyawa kalsilitik ID29533A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11824099P 1999-02-02 1999-02-02

Publications (1)

Publication Number Publication Date
ID29533A true ID29533A (id) 2001-09-06

Family

ID=22377367

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101673A ID29533A (id) 1999-02-02 2000-02-02 Senyawa-senyawa kalsilitik

Country Status (24)

Country Link
US (1) US6417215B1 (id)
EP (1) EP1148876A4 (id)
JP (1) JP2002536330A (id)
KR (1) KR20010093285A (id)
CN (1) CN1346269A (id)
AP (1) AP2001002220A0 (id)
AU (1) AU3480200A (id)
BG (1) BG105847A (id)
BR (1) BR0007922A (id)
CA (1) CA2361589A1 (id)
CO (1) CO5251439A1 (id)
CZ (1) CZ20012797A3 (id)
EA (1) EA200100854A1 (id)
HK (1) HK1042036A1 (id)
HU (1) HUP0200121A3 (id)
ID (1) ID29533A (id)
IL (1) IL144470A0 (id)
MA (1) MA25379A1 (id)
NO (1) NO20013769L (id)
OA (1) OA11757A (id)
PE (1) PE20001456A1 (id)
SK (1) SK10982001A3 (id)
WO (1) WO2000045816A1 (id)
ZA (1) ZA200106298B (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1308436B1 (en) * 2000-08-11 2008-10-15 Japan Tobacco Inc. Calcium receptor antagonists
JP2004514659A (ja) * 2000-10-25 2004-05-20 スミスクライン・ビーチャム・コーポレイション カルシライティック化合物
US6864267B2 (en) * 2001-07-16 2005-03-08 Smithkline Beecham Corporation Calcilytic compounds
MY143244A (en) * 2002-11-26 2011-04-15 Smithkline Beecham Corp Calcilytic compounds
WO2004069793A2 (en) 2003-01-28 2004-08-19 Bristol-Myers Squibb Company Novel 2-substituted cyclic amines as calcium sensing receptor modulators
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
EP1619180B1 (en) 2003-04-23 2009-12-16 Japan Tobacco Inc. CaSR ANTAGONIST
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
WO2004106280A1 (ja) * 2003-05-28 2004-12-09 Japan Tobacco Inc. ＣａＳＲアンタゴニスト
EP1964548A1 (en) * 2007-03-02 2008-09-03 Novartis AG Pharmaceutical compositions comprising a calcilytic agent
AU2009255156B2 (en) * 2008-06-05 2013-03-14 Asahi Kasei Pharma Corporation Sulfonamide compound and application thereof
WO2010103429A1 (en) 2009-03-10 2010-09-16 Pfizer Inc. 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
WO2021029517A1 (en) * 2019-08-13 2021-02-18 Dongguk University Industry-Academic Cooperation Foundation Pharmaceutical composition for improving or treating post-surgical hypoparathyroidism and treatment method using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122010000024I1 (de) * 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
DE4102024A1 (de) 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
WO1997037967A1 (en) * 1996-04-09 1997-10-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
UY24949A1 (es) * 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Also Published As

Publication number Publication date
NO20013769L (no) 2001-09-26
MA25379A1 (fr) 2002-04-01
CO5251439A1 (es) 2003-02-28
WO2000045816A1 (en) 2000-08-10
SK10982001A3 (sk) 2001-12-03
EA200100854A1 (ru) 2002-02-28
HUP0200121A2 (hu) 2002-05-29
ZA200106298B (en) 2002-10-18
KR20010093285A (ko) 2001-10-27
CZ20012797A3 (cs) 2002-01-16
BG105847A (en) 2002-04-30
CN1346269A (zh) 2002-04-24
JP2002536330A (ja) 2002-10-29
AU3480200A (en) 2000-08-25
US6417215B1 (en) 2002-07-09
OA11757A (en) 2005-07-19
PE20001456A1 (es) 2001-01-28
AP2001002220A0 (en) 2001-09-30
IL144470A0 (en) 2002-05-23
CA2361589A1 (en) 2000-08-10
NO20013769D0 (no) 2001-08-01
HK1042036A1 (zh) 2002-08-02
HUP0200121A3 (en) 2002-11-28
EP1148876A4 (en) 2003-07-23
EP1148876A1 (en) 2001-10-31
BR0007922A (pt) 2001-11-06

Similar Documents

Publication Publication Date Title
EE200100502A (et) Ühendid
PT1202994E (pt) Novos compostos
EE200200224A (et) Uudsed ühendid
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1224180E (pt) Azois substituidos
ATA51899A (de) Handstempel
IS6139A (is) Ný efnasambönd
DE60045545D1 (de) Klebefolie
NO20013769D0 (no) Kalsilytiske forbindelser
NO20020773D0 (no) Borkronekobling
NO20020466L (no) Kalsilytiske forbindelser
IS6141A (is) Ný efnasambönd
NO20014262D0 (no) Tiazoloindolinon-forbindelser
NO20022927L (no) Substituerte pyrrazoler
ATA121799A (de) Ausbeulgerät
ID29984A (id) Senyawa-senyawa bis-stirilbifenil
DE50003921D1 (de) Substituierte phenyluracile
ATA107599A (de) Heizwasserbereiter
SE9902762D0 (sv) New compounds
SE9904228D0 (sv) New compounds
SE9904422D0 (sv) New compounds
SE9904418D0 (sv) New compounds
SE9904420D0 (sv) New compounds
SE9900086D0 (sv) New compounds
SE9900071D0 (sv) New compounds